MuSK MG clinical trials at University of California Health

1 in progress, 0 open to eligible people

Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis
Sorry, not currently recruiting here
Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple ascending doses of CNP-106.
at UC Irvine

Our lead scientists for MuSK MG research studies include Ali A Habib, MD.

Last updated: June 25, 2024